US tech titans Elon Musk, Mark Zuckerberg and Jeff Bezos are taking a prominent place in the new Trump era, but another player from another era -- Oracle boss Larry Ellison -- is making a surprise return.

Billionaire Larry Ellison’s backing of Stargate could help grease the wheels for the embattled merger between Paramount Global and Skydance Media, sources told The Post.

Oracle founder Larry Ellison said the Stargate project, a joint venture with OpenAI and Softbank, will help to fuel the development of a cancer vaccine.

Yes, that's the name of a 1994 Roland Emmerich movie. It's now a big infrastructure project to help power tech giants' foray into AI.

He previously floated a joint venture, saying that the US should be entitled to half of the app.

What is Larry Ellison's net worth in 2025? What are the secrets behind the 80-year-old from New York City, who is currently considered the second-wealthiest man in the world behind

MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to represent a sustainable long-term revenue generator.

US President Donald Trump he would be open to tech billionaire Elon Musk – the owner of social media platform X – buying Chinese-owned app TikTok.

During a press conference on Tuesday afternoon, President Donald Trump floated the idea of Elon Musk or Larry Ellison purchasing TikTok, while also proposing that the U.S. government take a significant share of the transaction.

Billionaire Larry Ellison’s support for Stargate, a $500B AI infrastructure project endorsed by President Trump, could smooth the path for the

As 2024 was drawing to a close, OpenAI CEO Sam Altman faced two major problems. He wasn’t getting enough server capacity from Microsoft, his company’s biggest backer, to stay ahead of rivals developing artificial intelligence.

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every